✦ LIBER ✦

Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis

✍ Scribed by Nelson Leung; Angela Dispenzieri; Fernando C. Fervenza; Martha Q. Lacy; Rafael Villicana; Joao L. Cavalcante; Morie A. Gertz

Book ID: 114467110
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 215 KB
Volume: 46
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2005.05.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute renal insufficiency after high-dos

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

✍ Nelson Leung; Jeff M. Slezak; Erik J. Bergstralh; Angela Dispenzieri; Martha Q. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Risk-adjusted manipulation of melphalan

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

✍ Gertz, M A; Lacy, M Q; Dispenzieri, A; Ansell, S M; Elliott, M A; Gastineau, D A 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Febrile Reactions Occurring With Second

Febrile Reactions Occurring With Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis: A “Melphalan Recall” Reaction

✍ M.A. Rosenzweig; D.C. Seldin; D. Remick; M. Skinner; K. Quillen; B. Oran; K.T. F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

High-dose melphalan is an effective salv

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

✍ Gesine Bug; Johannes Atta; Stefan A. Klein; Bernd Hertenstein; Lothar Bergmann; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 107 KB

Treatment-Related Mortality in Patients

✍ V. Sanchorawala; M. Skinner; K.T. Finn; K. Quillen; D.C. Seldin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

High-dose melphalan and stem cell transp

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

✍ Tsai, S. B.; Seldin, D. C.; Quillen, K.; Berk, J. L.; Ruberg, F. L.; Meier-Ewert 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 161 KB